# Rui Yamaguchi

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/rui-yamaguchi/

## Facts

| Field | Value |
| --- | --- |
| Citations | 7,033 |
| Field | Gene expression and cancer classification |
| h-index | 43 |
| i10-index | 116 |
| Last Known Institution | Human Genome Sciences (United States) |
| OpenAlex ID | https://openalex.org/A5078146127 |
| ORCID iD | 0000-0003-1224-227X |
| Works | 312 |

## Researcher papers

- [Identification of Genes Upregulated in <i>ALK</i> -Positive and <i>EGFR/KRAS/ALK</i> -Negative Lung Adenocarcinomas](https://scholariq.org/papers/identification-of-genes-upregulated-in-i-alk-i-positive-and-i-egfr-kras-alk-i/)
- [Senolysis by glutaminolysis inhibition ameliorates various age-associated disorders](https://scholariq.org/papers/senolysis-by-glutaminolysis-inhibition-ameliorates-various-age-associated/)
- [Molecular features of triple negative breast cancer cells by genome-wide gene expression profiling analysis](https://scholariq.org/papers/molecular-features-of-triple-negative-breast-cancer-cells-by-genome-wide-gene/)
- [Epithelial-to-Mesenchymal Transition is a Cause of Both Intrinsic and Acquired Resistance to KRAS G12C Inhibitor in KRAS G12C–Mutant Non–Small Cell Lung Cancer](https://scholariq.org/papers/epithelial-to-mesenchymal-transition-is-a-cause-of-both-intrinsic-and-acquired/)
- [Epidermal Growth Factor Receptor Tyrosine Kinase Defines Critical Prognostic Genes of Stage I Lung Adenocarcinoma](https://scholariq.org/papers/epidermal-growth-factor-receptor-tyrosine-kinase-defines-critical-prognostic/)
- [Circulating exosomal microRNA-203 is associated with metastasis possibly via inducing tumor-associated macrophages in colorectal cancer](https://scholariq.org/papers/circulating-exosomal-microrna-203-is-associated-with-metastasis-possibly-via/)
- [Modeling gene expression regulatory networks with the sparse vector autoregressive model](https://scholariq.org/papers/modeling-gene-expression-regulatory-networks-with-the-sparse-vector/)
- [Antigen delivery targeted to tumor-associated macrophages overcomes tumor immune resistance](https://scholariq.org/papers/antigen-delivery-targeted-to-tumor-associated-macrophages-overcomes-tumor-immune/)
- [Quantitative characterization of T-cell repertoire in allogeneic hematopoietic stem cell transplant recipients](https://scholariq.org/papers/quantitative-characterization-of-t-cell-repertoire-in-allogeneic-hematopoietic/)
- [Whole-genome sequencing and comprehensive variant analysis of a Japanese individual using massively parallel sequencing](https://scholariq.org/papers/whole-genome-sequencing-and-comprehensive-variant-analysis-of-a-japanese/)
- [ARAF Amplification in Small-Cell Lung Cancer-Transformed Tumors Following Resistance to Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitors](https://scholariq.org/papers/araf-amplification-in-small-cell-lung-cancer-transformed-tumors-following/)

## Researcher topics

- [Gene expression and cancer classification](https://scholariq.org/topics/gene-expression-and-cancer-classification/)
- [Bioinformatics and Genomic Networks](https://scholariq.org/topics/bioinformatics-and-genomic-networks/)
- [Gene Regulatory Network Analysis](https://scholariq.org/topics/gene-regulatory-network-analysis/)
- [Cancer Genomics and Diagnostics](https://scholariq.org/topics/cancer-genomics-and-diagnostics/)
- [Lung Cancer Treatments and Mutations](https://scholariq.org/topics/lung-cancer-treatments-and-mutations/)

## Researcher university

- [Human Genome Sciences (United States)](https://scholariq.org/institutions/human-genome-sciences-united-states/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.